Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway

INTRODUCTION: Cell-based therapy represents a new frontier in the treatment of a wide variety of human diseases traditionally associated with morbidity outcomes, including those involving inflammation, autoimmunity, tissue damage, and cancer. However, the use of mesenchymal stem cells (MSCs) to trea...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Atsuta, Ikiru, Liu, Shiyu, Miura, Yasuo, Akiyama, Kentaro, Chen, Chider, An, Ying, Shi, Songtao, Chen, Fa-Ming
Format:	Artigo
Sprog:	Inglês
Udgivet:	BioMed Central 2013
Fag:	Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3854680/ https://ncbi.nlm.nih.gov/pubmed/24025590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/scrt322
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway

Lignende værker